Privacy Policy for all Study subjects (Australia and Hong Kong)

AI Software, Inc. has created this privacy statement in order to demonstrate and explain our commitment to the privacy  of your personal information when visiting the AI Software, Inc. website Р

AI Software, Inc. only gathers necessary and important information from you in connection with this related service so you can see the instructions from the Study sponsor NGM Biopharmaceuticals, Inc. on how to self-inject your Study Drug for the Study. AI Software, Inc. does not require that you as a user give us your personal contact and other personal information. If our requirements change, AI Software, Inc. may ask your permission for additional personal information.

AI Software, Inc. may track and analyze non-identifying and aggregate usage and volume statistical information for internal use – information will not be provided to companies outside AI Software, Inc. AI Software, Inc. may collect certain other, usually technical information from you when you visit the Study’s webpages, such as your IP address. This information is logged to help diagnose technical problems and to administer the Study’s webpages.

The Study’s website will not contain links to other sites. AI Software, Inc. is responsible for the privacy practices of other sites and is to ensure that the Study’s website will not be cojoined with any other webpages of other customers.

Hosting of the AI Software, Inc. Study website is done in a secure server environment that uses a firewall and other technology to help prevent tampering from outside intruders. To prevent unauthorized access, maintain data accuracy, and ensure the correct use of information, AI Software, Inc. has put into place, appropriate physical, electronic, and managerial procedures to safeguard and secure the information we collect online.

AI Software, Inc. reserves the right to change this statement only with permission of the study Sponsor and its clinical research organization Medpace. Questions regarding this statement or the practices of AI Software, Inc. should be directed to